Outcomes of cardiac surgery in patients with end-stage renal disease: Insights from the Israel national registries.
cardiovascular research
coronary artery disease
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
17
10
2021
received:
28
07
2021
accepted:
02
11
2021
pubmed:
4
2
2022
medline:
4
3
2022
entrez:
3
2
2022
Statut:
ppublish
Résumé
End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry. The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center. One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2-18.2), MVR procedure (HR = 1.5, 95% CI; 1.04-2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2-2.04). Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
Sections du résumé
BACKGROUND
BACKGROUND
End-stage renal disease (ESRD) has been shown to be associated with increased mortality in patients undergoing cardiac surgery. We aimed to compare the short- and mid-term mortality after cardiac surgery of patients with dialysis-dependent ESRD (DD-ESRD) to patients with normal renal function (NRF), using national registries: the ESRD registry, the adult cardiac surgery registry (ACSR), and the National Mortality Registry.
METHODS
METHODS
The study population comprised 8207 adult patients who underwent either isolated coronary artery bypass grafting (CABG), isolated aortic valve replacement (AVR), isolated mitral valve replacement (MVR), or CABG + valve-related procedure, between January 2017 and April 2019. Data were retrospectively extracted and reported to the ACSR by the department of medical records of each medical center.
RESULTS
RESULTS
One hundred and four DD-ESRD patients (mean age 63.2 ± 8.8 years, 83.7% males) were compared with 8103 NRF patients (mean age 64.9 ± 9.8 years, 77.6% males). Median follow-up for the total cohort was of 32.0 months (IQR; 25.0, 40.0). In DD-ESRD compared to NRF patients, 30-day mortality was higher (14.4% vs. 2.3%, respectively, p = 0.0001) and 4-year survival was significantly lower (44% ± 0.06 vs. 91% ± 0.04, respectively, p = 0.0001). Fifty-three percent of DD-ESRD 30-day mortality was caused by sepsis. Risk factors associated with reduced midterm survival included: DD-ESRD patients (HR = 4.7, 95% CI; 1.2-18.2), MVR procedure (HR = 1.5, 95% CI; 1.04-2.1) and combined CABG + valve-related procedure (HR = 1.6, 95% CI; 1.2-2.04).
CONCLUSIONS
CONCLUSIONS
Preoperative DD-ESRD was associated with a significant increase in 30-day and mid-term mortality after cardiac surgery. The highest mortality rate was observed in valvular and combined procedures.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
760-768Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Goździk AT, Jakubaszko J, Grzebieniak T, Kustrzycki W, Goździk W. Does the stage of chronic kidney failure influence the outcome in cardiac surgery? Adv Clin Exp Med. 2015;24(5):845-850.
Bäck C, Hornum M, Møller CJH, Olsen PS. Cardiac surgery in patients with end-stage renal disease on dialysis. Scand Cardiovasc J. 2017;51(6):334-338.
Xing D, Hage FG, Chen Y-F, et al. Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. Am J Pathol. 2008;172(1):22-30.
Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. 2001;38(5):992-1000.
Shroff GR, Chang TI. Risk stratification and treatment of coronary disease in chronic kidney disease and end-stage kidney disease. Semin Nephrol. 2018;38(6):582-599.
Park JH, Lim J-H, Lee KH, et al. Outcomes of open heart surgery in patients with end-stage renal disease. Kidney Res Clin Pract. 2019;38(3):399-406.
Windecker S, Kolh P, Alfonso F, et al. ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2014;10(9):1024-1094. https://plus.rjl.se/info_files/infosida39946/ESC2014_myocardial_revascularisation.pdf
Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;145:e18-e114.
Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012;23(12):2042-2049.
Mourad F, Cleve N, Nowak J, et al. Long-term single-center outcomes of patients with chronic renal dialysis undergoing cardiac surgery. Ann Thorac Surg. 2020;109(5):1442-1448.
Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70(11):2021-2030.
Israeli National Dialysis Registry in the Israeli Ministry of Health. 2021. https://www.health.gov.il/UnitsOffice/ICDC/disease_Registries/Pages/Alternative_kidney_treatment.aspx
Israeli National Cardiac Surgery Database at the Israeli Ministry of Health. 2021. Available from: https://www.health.gov.il/UnitsOffice/ICDC/disease_Registries/Pages/Cardiac_Surgery_Registry.aspx
Wang Z, Gong Y, Fan F, et al. Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis. Ren Fail. 2020;42(1):107-112.
Rahmanian PB, Adams DH, Castillo JG, Vassalotti J, Filsoufi F. Early and late outcome of cardiac surgery in dialysis-dependent patients: single-center experience with 245 consecutive patients. J Thorac Cardiovasc Surg. 2008;135(4):915-922.
Marui A, Kimura T, Nishiwaki N, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014;114(4):555-561.
Nicolini F, Fragnito C, Molardi A, et al. Heart surgery in patients on chronic dialysis: is there still room for improvement in early and long-term outcome? Heart Vessels. 2011;26(1):46-54.
Horst M, Mehlhorn U, Hoerstrup SP, Suedkamp M, de Vivie ER. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg. 2000;69(1):96-101.
Thakar CV, Yared J-P, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64(1):239-246.
Silva J, Hoeksema H, Fekety FR. Transient defects in phagocytic functions during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1974;67(2):175-183.
De Angeli S, Paccagnella A, Mordacchini M, et al. The effects of prolonged cardiopulmonary bypass on cell-mediated immunity. Thorac Cardiovasc Surg. 1994;42(1):14-20.
Parker DJ, Cantrell G, Stroud R, Karp R, Digerness SB. Changes in serum complement and the immunoglobulins after cardiopulmonary bypass. Br J Surg. 1972;59(11):910-911.
Yellin A, Refaely Y, Paley M, Simansky D. Major bleeding complicating deep sternal infection after cardiac surgery. J Thorac Cardiovasc Surg. 2003;125(3):554-558.
Liu JY, Birkmeyer NJ, Sanders JH, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 2000;102(24):2973-2977.
Kogan A, Medalion B, Kornowski R, et al. Cardiac surgery in patients on chronic hemodialysis: short and long-term survival. Thorac Cardiovasc Surg. 2008;56(3):123-127.
Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Adams DH. Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest. 2008;133(3):713-721.
Bechtel JF, Detter C, Fischlein T, et al. Cardiac surgery in patients on dialysis: decreased 30-day mortality, unchanged overall survival. Ann Thorac Surg. 2008;85(1):147-153.
Horai T, Fukui T, Tabata M, Takanashi S. Early and mid-term results of off-pump coronary artery bypass grafting in patients with end stage renal disease: surgical outcomes after achievement of complete revascularization. Interact Cardiovasc Thorac Surg. 2008;7(2):218-221.
Haviv YS, Golan E. Global Dialysis Perspective: Israel. Kidney360. 2020.1(2):119-122. https://kidney360.asnjournals.org/content/1/2/119
Pippias M, Kramer A, Noordzij M, et al. The European Renal Association-European Dialysis and Transplant Association Registry Annual Report 2014: a summary. Clin Kidney J. 2017;2:154-169.
Blumenfeld O, Na'amnih W, Shapira-Daniels A, Lotan C, Shohat T, Shapira OM. Trends in coronary revascularization and ischemic heart disease-related mortality in Israel. J Am Heart Assoc. 2017;6(2):e004734.
Bundhun PK, Bhurtu A, Chen M-H. Impact of coronary artery bypass surgery and percutaneous coronary intervention on mortality in patients with chronic kidney disease and on dialysis: A systematic review and meta-analysis. Medicine. 2016;95(27):e4129.